Rising Short Interest in Biotech Stocks

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

The short interest data is out for the August 15 settlement date. Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts, potentially coming from a failed clinical study or even not getting an FDA approval. In an industry like this, it takes courage to bet on the outcomes. Betting on the shorts in this industry is not for the risk-averse, and rarely does news from clinical trials, projects or the FDA have just a small impact on the share price.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) saw increased in its short interest to 4.033 million, with 3.87 days to cover, as of August 15. This was up from the previous period’s 3.955 million shares short. Alexion shares recently have been trading toward the high end of their 52-week range of $100.89 to $185.43.

Amgen Inc. (NASDAQ: AMGN) continues the trend of increasing its short interest, reporting it at 10.8 million shares, with 2.9 days to cover. That was is up from 9.5 million on the July 31 settlement date. Accordingly the increased short interest shows investors betting against Amgen, which has been reaching new 52-week highs throughout August. In the past year shares have traded in a range of $105.76 to $137.99.

Biogen Idec Inc. (NASDAQ: BIIB) also posted an increase in short interest for the August 15 settlement date. The number of shares short was 3.3 million, with 2.8 days to cover. This was up from 2.9 million in the previous period. Biogen shares have trended upward over the past year and are approaching its 52-week high of $358.89.

Celgene Corp. (NASDAQ: CELG) saw its short interest remain basically unchanged around 13.0 million shares, with 3.56 days to cover. The stock hit its all-time high Wednesday, and shares have traded in a range of $66.85 to $96.15 over the past year.

MannKind Corp. (NASDAQ: MNKD) continued the trend of increasing short interest, to 77.3 million shares short, with 4.5 days to cover, up from the previous 72.5 million. This trend has played on the falling share price, which has been declining since July. MannKind closed Tuesday at $7.28, and has a 52-week range of $3.80 to $11.48.

READ ALSO: Stocks With the Largest Short Interest

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618